Literature DB >> 23677325

Seroprevalence of antipolio antibodies among children <15 years of age in border provinces in China.

HaiBo Wang1, Hui Cui, ZhenGrong Ding, Pian Ba, ShuangLi Zhu, Ning Wen, LiXin Hao, Jing Ning, Jie Zhang, De Yang, WenBo Xu, Yong Zhang, ChunXiang Fan, WenZhou Yu, XiaoFeng Liang, HuiMing Luo.   

Abstract

Despite remarkable progression toward polio eradication worldwide, wild poliovirus (WPV) importation has been a great challenge for China, as it shares borders with countries where WPV is endemic. The objective of this study was to estimate poliovirus antibody seroprevalence among children <15 years of age in 3 border provinces (Yunnan Province, Tibet Autonomous Region, and Xinjiang Uygur Autonomous Region) in China. A cross-sectional, hospital-based study was undertaken in 3 border provinces in 2010. Individuals <15 years old who visited hospitals at the prefecture level or above to have their blood drawn for any reason were invited to participate in our study. Neutralizing antibody titers to polio serotypes 1 (P1), P2, and P3 were assayed according to the World Health Organization manual for the virological investigation of polio. Antibody titers of ≥8 were considered positive. Among the 1,360 subjects enrolled, 1,220 (89.7%), 1,259 (92.6%), and 1,112 (81.8%) were seropositive to P1, P2, and P3, respectively, and 1,051 (77.3%) subjects were seropositive to all three serotypes. The highest seropositive rates were observed in Xinjiang Uygur Autonomous Region. By age, 3- to 5-year-old subjects had the highest rate of seropositivity, and seropositivity decreased significantly with increasing age. The risk of WPV importation will continue until WPV transmission has been interrupted worldwide. Consistent with the Global Polio Eradication Initiative's polio endgame strategy, China must maintain its polio-free status by ensuring adequate population immunity against polio. Because immunity wanes with increasing age, a booster dose with bivalent type 1 and 2 oral poliovirus vaccine could be considered for teenagers in China.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23677325      PMCID: PMC3697440          DOI: 10.1128/CVI.00092-13

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  38 in total

1.  Immunity to poliomyelitis in The Netherlands.

Authors:  M A Conyn-Van Spaendonck; H E de Melker; F Abbink; N Elzinga-Gholizadea; T G Kimman; T van Loon
Journal:  Am J Epidemiol       Date:  2001-02-01       Impact factor: 4.897

2.  Wild poliovirus imported into Qinghai province, China.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2000-02-18

3.  Seroprevalence to polio in personnel at a virology institute.

Authors:  B D Schoub; N K Blackburn; J M McAnerney
Journal:  J Infect       Date:  2001-08       Impact factor: 6.072

4.  A case of poliomyelitis associated with infection of wild poliovirus in Qinghai Province, China, in October 1999.

Authors:  Y Chiba; H Murakami; M Kobayashi; H Shimizu; H Yoshida; T Yoneyama; T Miyamura; Y Jingjin; Z Libi
Journal:  Jpn J Infect Dis       Date:  2000-06       Impact factor: 1.362

5.  [German Health survey 1997/98: immune status against poliomyelitis].

Authors:  S Diedrich; H Claus; W Thierfelder; B M Bellach; E Schreier
Journal:  Dtsch Med Wochenschr       Date:  2000-05-12       Impact factor: 0.628

6.  Progress toward interruption of wild poliovirus transmission--worldwide, January 2010-March 2011.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-05-13       Impact factor: 17.586

7.  Importation of wild poliovirus into Qinghai Province--China, 1999.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2000-02-18       Impact factor: 17.586

8.  Progress toward poliomyelitis eradication--Myanmar, 1996-1999.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1999-10-29       Impact factor: 17.586

9.  Outbreak of poliomyelitis--Cape Verde, 2000.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2000-12-01       Impact factor: 17.586

10.  Immunity status against poliomyelitis in Germany: determination of cut-off values in International Units.

Authors:  Sabine Diedrich; Hermann Claus; Eckart Schreier
Journal:  BMC Infect Dis       Date:  2002-02-06       Impact factor: 3.090

View more
  8 in total

1.  Apropos "seroprevalence of antipolio antibodies among children <15 years of age in border provinces in China".

Authors:  Subhash C Arya; Nirmala Agarwal
Journal:  Clin Vaccine Immunol       Date:  2013-10

2.  Immunity to polio, measles and rubella in women of child-bearing age and estimated congenital rubella syndrome incidence, Cambodia, 2012.

Authors:  B Mao; K Chheng; K Wannemuehler; E Vynnycky; S Buth; S C Soeung; S Reef; W Weldon; L Quick; C J Gregory
Journal:  Epidemiol Infect       Date:  2014-11-06       Impact factor: 4.434

3.  An outbreak following importation of wild poliovirus in Xinjiang Uyghur Autonomous Region, China, 2011.

Authors:  Hai-Bo Wang; Wen-Zhou Yu; Xin-Qi Wang; Fuerhati Wushouer; Jian-Ping Wang; Dong-Yan Wang; Fu-Qiang Cui; Jing-Shan Zheng; Ning Wen; Yi-Xin Ji; Chun-Xiang Fan; Hui-Ling Wang; Gui-Jun Ning; Guo-Hong Huang; Dong-Mei Yan; Qi-Ru Su; Da-Wei Liu; Guo-Min Zhang; Kathleen H Reilly; Jing Ning; Jian-Ping Fu; Sha-Sha Mi; Hui-Ming Luo; Wei-Zhong Yang
Journal:  BMC Infect Dis       Date:  2015-01-31       Impact factor: 3.090

4.  Cross-border collaboration between China and Myanmar for emergency response to imported vaccine derived poliovirus case.

Authors:  Hai-Bo Wang; Li-Fen Zhang; Wen-Zhou Yu; Ning Wen; Dong-Mei Yan; Jing-Jing Tang; Yong Zhang; Chun-Xiang Fan; Kathleen H Reilly; Wen-Bo Xu; Li Li; Zheng-Rong Ding; Hui-Ming Luo
Journal:  BMC Infect Dis       Date:  2015-01-17       Impact factor: 3.090

5.  Enhanced surveillance of acute flaccid paralysis following importation of wild poliovirus in Xinjiang Uygur Autonomous Region, China.

Authors:  Ning Wen; Chun-Xiang Fan; Jian-Ping Fu; Jing Ning; Yi-Xin Ji; Hui-Ming Luo; Hua-Qing Wang; Shuang-Li Zhu; Wen-Zhou Yu; Hai-Bo Wang; Hui Zhu; Fu-Qiang Cui; De-Xin Li; Shi-Wen Wang; Wen-Bo Xu; Li-Xin Hao; Ling-Sheng Cao; Li Luo; Lu Han; Lei Cao; Wei Xia; Xin-Qi Wang; Kathleen H Reilly; Fuerhati Wushouer; Sha-Sha Mi; Wei-Zhong Yang; Li Li
Journal:  BMC Infect Dis       Date:  2014-02-27       Impact factor: 3.090

6.  Sero-survey of polio antibodies during wild poliovirus outbreak in southern Xinjiang Uygur Autonomous Region, China.

Authors:  Hai-Bo Wang; Shuang-Li Zhu; Jing-Shan Zheng; Ai-Li Gou; Hui Cui; Yong Zhang; Gui-Jun Ning; Chun-Xiang Fan; Yuan-Sheng Chen; Ke-Li Li; Ping Yuan; Chao Ma; Jing Ma; Hui Zheng; Xin-Chun Fan; Xin-Lan Li; Hai-Shu Tang; Xiao-Lei Li; Fan Zhang; Dong-Mei Yan; Dong-Yan Wang; Zhi-Qiang Cui; Li-Ping Ren; Hui Zhu; Hui-Ling Wang; Xiao-Hong Jiang; Hong-Qiu An; Yang Liu; Jing Li; Wen-Bo Xu; Ning Wen; Ai-Qiang Xu; Hui-Ming Luo
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

7.  Vaccine-derived poliovirus surveillance in China during 2001-2013: the potential challenge for maintaining polio free status.

Authors:  Hai-Bo Wang; Hui-Ming Luo; Li Li; Chun-Xiang Fan; Li-Xin Hao; Chao Ma; Qi-Ru Su; Hong Yang; Kathleen H Reilly; Hua-Qing Wang; Ning Wen
Journal:  BMC Infect Dis       Date:  2017-12-02       Impact factor: 3.090

8.  Factors determining anti-poliovirus type 3 antibodies among orally immunised Indian infants.

Authors:  Saravanakumar Puthupalayam Kaliappan; Srinivasan Venugopal; Sidhartha Giri; Ira Praharaj; Arun S Karthikeyan; Sudhir Babji; Jacob John; Jayaprakash Muliyil; Nicholas Grassly; Gagandeep Kang
Journal:  Vaccine       Date:  2016-08-24       Impact factor: 3.641

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.